Here’s what we actually know — and don’t yet know — about claims that a “natural enzyme” tested in a clinical trial cleared arterial plaque far better than statins.
🧬 1. New cholesterol drugs are in development — but none have proved to clear plaque 3× better than statins
Recent late‑stage trial results show that an experimental oral drug (an inhibitor targeting the PCSK9 protein) dramatically lowers LDL (“bad”) cholesterol — up to ~64.6% reduction — when added to statins, compared with other non‑statin therapies. High LDL reduction can reduce the risk of heart attacks and long‑term disease progression, but lowering cholesterol is not the same as clearing arterial plaque directly. (Reuters)
💊 2. Statins are proven to reduce cardiovascular risk — and help stabilize plaque
Statins have been the cornerstone of therapy for decades because:
- They lower LDL cholesterol
- They reduce inflammation inside arterial walls
- They stabilize existing atherosclerotic plaque, making plaques less likely to rupture
All of this strongly reduces heart attack and stroke risk. (Nature)
However, long‑term, consistent plaque regression beyond stabilization is modest in most traditional statin trials — not a dramatic “plaque removal.” That’s why researchers continue to explore new drugs.
🚫 3. Broad claims about a “natural enzyme clearing plaque 3× better” aren’t backed by strong evidence
As of now, there is no major peer‑reviewed randomized clinical trial showing a natural enzyme achieves three‑fold superior plaque clearance compared with statins in humans. Published scientific literature and major clinical news outlets have not reported such a result.
🔬 4. What is real science saying?
- Aggressive LDL reduction — whether with statins, newer medications like PCSK9 inhibitors, or combinations — may lead to small degrees of plaque regression in some patients when LDL levels are pushed very low over long periods. (Reddit)
- Research also shows that inflammation plays a role in plaque stability and cardiovascular risk, and some non‑cholesterol therapies (like colchicine or anti‑inflammatory approaches) are being studied for additional benefit. (American Heart Association Journals)
- Some newer therapies in development (e.g., gene‑targeting or novel PCSK9 inhibitors) may change expectations for what’s possible with LDL control, but they are not yet proven plaque‑clearing miracles in clinical practice. (Reddit)
📌 Bottom line
✔️ Statins and new cholesterol‑lowering drugs can significantly reduce LDL cholesterol and stabilize plaque.
✔️ Some patients may show modest plaque regression over many months or years with intense LDL reduction.
❌ There is currently no credible clinical trial proving a “natural enzyme” clears arterial plaque 3 × better than statins or overturns the fundamentals of cardiovascular medicine.
If you’d like, I can explain the difference between plaque stabilization and plaque regression and what current research says about how much arteries can truly “unclog” with treatment.
